Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Investigational New Drugs|October 12, 2010
Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium studyRobert J Morgan, Lucille Leong, Warren Chow, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesotheliomaSuresh S Ramalingam, Chandra P Belani, Christopher Ruel, et al.
Clinical Lung Cancer|August 4, 2019
Comparative Efficacy of Second- and Subsequent-line Treatments for Metastatic NSCLC: A Fractional Polynomials Network Meta-analysis of Cancer ImmunotherapiesChristian Schulz, David Gandara, Carmen G Berardo, et al.
JTO Clinical and Research Reports|September 10, 2025
Older Adult Participation in Early-Phase Lung Cancer Clinical Trials, 1998 to 2020Desirae Ehley, Lilit Vardanyan, Rebecca S Boxer, et al.
Cancer Genomics & Proteomics|September 30, 2008
Identification of F-box/LLR-repeated protein 17 as potential useful biomarker for breast cancer therapyGary Guishan Xiao, Bing-Sen Zhou, George Somlo, et al.
Analytical and Bioanalytical Chemistry|March 26, 2013
Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analysesL Renee Ruhaak, Sandra L Taylor, Suzanne Miyamoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancerHenry Wang, Janice Ryu, David Gandara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Integration of novel therapeutics into combined modality therapy of locally advanced non-small cell lung cancerDavid Gandara, Samir Narayan, Primo N Lara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Phase II trial of irinotecan and carboplatin for extensive or relapsed small-cell lung cancerGigi Chen, Minh Huynh, Lou Fehrenbacher, et al.
Frontiers in Immunology|November 6, 2025
Prognostic value of patient-reported outcomes for survival in patients with advanced lung cancer receiving immune checkpoint inhibitorsDavid Gandara, Miranda Gogishvili, Ahmet Sezer, et al.
Pageof 8